ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SLNO Soleno Therapeutics Inc

42.08
-0.55 (-1.29%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 415,961
Bid Price 40.33
Ask Price 44.20
News -
Day High 43.59

Low
3.69

52 Week Range

High
53.82

Day Low 41.89
Share Name Share Symbol Market Stock Type
Soleno Therapeutics Inc SLNO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.55 -1.29% 42.08 18:49:02
Open Price Low Price High Price Close Price Previous Close
43.05 41.89 43.59 42.08 42.63
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
5,337 415,961 US$ 42.60 US$ 17,720,528 - 3.69 - 53.82
Last Trade Type Quantity Price Currency
15:56:52 10 US$ 41.60 USD

Soleno Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.36B 32.46M - 0 -38.99M -1.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Soleno Therapeutics News

Date Time Source News Article
5/22/202415:05GlobeNewswire Inc.Soleno Therapeutics Announces Oral Presentation featuring..
5/22/202407:00GlobeNewswire Inc.Soleno Therapeutics to Participate in Upcoming Investor..
5/15/202407:00GlobeNewswire Inc.Soleno Therapeutics Stands with the Prader-Willi Syndrome..
5/09/202415:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202415:05GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports..
5/07/202416:28Edgar (US Regulatory)Form 8-K - Current report
5/06/202415:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
5/02/202421:32GlobeNewswire Inc.Soleno Therapeutics Announces Pricing of Approximately $138..
5/02/202415:01GlobeNewswire Inc.Soleno Therapeutics Announces Proposed Public Offering of..
4/30/202407:00GlobeNewswire Inc.Soleno Therapeutics Announces Peer-Reviewed Publication of..
4/29/202407:00GlobeNewswire Inc.Soleno Therapeutics Receives Breakthrough Therapy..
4/19/202415:05GlobeNewswire Inc.Soleno Therapeutics Announces Inducement Grants Under Nasdaq..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SLNO Message Board. Create One! See More Posts on SLNO Message Board See More Message Board Posts

Historical SLNO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week41.3643.7339.6441.61315,8200.721.74%
1 Month47.1448.4939.6444.47436,693-5.06-10.73%
3 Months44.2653.8036.6143.31424,401-2.18-4.93%
6 Months28.4553.8227.2742.41381,18313.6347.91%
1 Year5.3053.823.6931.34497,83436.78693.96%
3 Years1.0453.820.13026.86860,09041.043,946.15%
5 Years2.9053.820.13025.29747,69939.181,351.03%

Soleno Therapeutics Description

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.

Your Recent History

Delayed Upgrade Clock